Arvinas Holding Company LLC (ARVN)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

395 WINCHESTER AVE NEW HAVEN, CT 06511

Arvinas, Inc. operates as a bio-pharmaceutical company. The Company develops protein degradation therapeutics for cancers and other diseases. Arvinas serves health care industry worldwide.

Data as of 2020-07-04
Market Cap1.326 Billion Shares Outstanding39.15 Million Avg 30-day Volume805.629 Thousand
P/E Ratio Dividend Yield EPS-2.24
Price/Sales32.207 Price cash flow ratio25.6 Price free cash flow ratio-37.5
Book Value5.41 Price to Tangible Book6.32 Alpha
Short Interest Ratio % Short Interest to Float R-squared
BETA 52-week High/Low61.57 / 15.185 Stddev
View SEC Filings from ARVN instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 7 4 (0.26%)
13F Filers holding this stock: 123 47 (3.08%)
Aggregate 13F shares on 03/31/2020: 31.994 Million 17.969 Million
Aggregate 13F shares on 12/31/2019: 30.169 Million 17.824 Million
Percent change: 6.05% 0.82%
Funds creating new positions: 27 9
Funds Adding to an existing position: 51 19
Funds closing out their position: 27 15
Funds reducing their position: 31 13
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ARVN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ARVN BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

5 Thousand total shares from 2 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

19.4 Thousand total shares from 2 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

PARMAR KUSH

  • Director
  • 10% Owner
4,605,784 2020-06-30 2

DIXON WENDY L

  • Director
14,243 2020-06-30 2

MORRISON BRIGGS

  • Director
4,800 2020-06-23 2

SHANNON TIMOTHY M

  • Director
4,569,100 2020-06-17 4

NORWALK LESLIE V

  • Director
4,909 2020-06-17 3

BAIN LINDA

  • Director
0 2020-06-10 2

RATCLIFFE LIAM

  • Director
0 2020-06-03 3

LOVEN JAKOB

  • Director
0 2020-06-03 1

KENNEDY EDWARD MOORE JR.

  • Director
0 2020-06-03 1

MARGUS BRADLEY ALBERT

  • Director
0 2020-06-03 3

SMALDONE ALSUP LAURIE

  • Director
0 2020-06-03 3

CASSIDY SEAN A CHIEF FINANCIAL OFFICER

  • Officer
151,778 2020-05-13 9

ORBIMED ADVISORS LLC

ORBIMED CAPITAL GP VI LLC

  • Director
  • 10% Owner
2,765,717 2020-04-24 0

RA CAPITAL MANAGEMENT, L.P.

RA CAPITAL HEALTHCARE FUND LP

KOLCHINSKY PETER

  • Director
  • 10% Owner
0 2020-04-02 0

HOUSTON JOHN G PRESIDENT AND CEO

  • Officer
  • Director
816,200 2020-03-23 4

TAYLOR IAN CHIEF SCIENTIFIC OFFICER

  • Officer
70,398 2020-03-19 6

PECK RONALD CHIEF MEDICAL OFFICER

  • Officer
0 2020-02-27 3

CANAAN IX L.P.

CANAAN PARTNERS IX LLC

  • 10% Owner
7,925,919 2020-01-14 0

5AM VENTURES III, L.P.

5AM PARTNERS III, LLC

5AM CO-INVESTORS III, L.P.

DIEKMAN JOHN D

ROCKLAGE SCOTT M

SCHWAB ANDREW J.

  • 10% Owner
3,316,059 2019-09-16 1

CREW ANDREW SEE REMARKS

  • Officer
0 2019-03-01 0

FLYNN JAMES E

DEERFIELD MGMT L.P.

DEERFIELD MGMT III, L.P.

DEERFIELD MGMT IV, L.P.

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

DEERFIELD SPECIAL SITUATIONS FUND, L.P.

DEERFIELD PRIVATE DESIGN FUND III, L.P.

DEERFIELD PRIVATE DESIGN FUND IV, L.P.

  • 10% Owner
  • POSSIBLE MEMBER OF A 10% GROUPPOSSIBLE MEMBER OF A 10% GROUPPOSSIBLE MEMBER OF A 10% GROUPPOSSIBLE MEMBER OF A 10% GROUPPOSSIBLE MEMBER OF A 10% GROUPPOSSIBLE MEMBER OF A 10% GROUPPOSSIBLE MEMBER OF A 10% GROUPPOSSIBLE MEMBER OF A 10% GROUP
No longer subject to file 2018-10-01 0

ELM STREET VENTURES L P

ELM STREET VENTURE ASSOCIATES, LLC

BETTIGOLE ROBERT A.

  • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
No longer subject to file 2018-10-01 0

CONNECTICUT INNOVATIONS INC

  • 10% Owner
0 2018-09-26 0

CRAIG M. CREWS FAMILY 2013 TRUST

  • 10% Owner
560,000 2018-09-26 0

NEW LEAF VENTURES III, L.P.

NEW LEAF VENTURE ASSOCIATES III, L.P.

NEW LEAF VENTURE MANAGEMENT III, L.L.C.

  • 10% Owner
0 2018-09-26 0

CREWS CRAIG MARTIN

  • 10% Owner
0 2018-09-26 0

CREWS FAMILY 2018 TRUST

  • 10% Owner
538,461 2018-09-26 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

DIXON WENDY L - Director

2020-06-29 A 24,000 a 24,000 0.00 direct

SHANNON TIMOTHY M - Director

2020-06-17 P 2,000 $30.26 a 79,546 4,569,100.00 direct

BAIN LINDA - Director

2020-06-10 A 24,000 a 24,000 0.00 direct

LOVEN JAKOB - Director

2020-06-03 A 12,000 a 12,000 0.00 direct

SMALDONE ALSUP LAURIE - Director

2020-06-03 A 12,000 a 12,000 0.00 direct

SHANNON TIMOTHY M - Director

2020-06-03 A 12,000 a 12,000 4,567,100.00 direct

KENNEDY EDWARD MOORE JR. - Director

2020-06-03 A 12,000 a 12,000 0.00 direct

RATCLIFFE LIAM - Director

2020-06-03 A 12,000 a 12,000 0.00 direct

MARGUS BRADLEY ALBERT - Director

2020-06-03 A 12,000 a 12,000 0.00 direct

MORRISON BRIGGS - Director

2020-06-03 A 12,000 a 12,000 0.00 direct

NORWALK LESLIE V - Director

2020-06-03 A 12,000 a 12,000 0.00 direct

SHANNON TIMOTHY M - Director

2020-06-02 P 3,000 $32.30 a 77,546 4,567,100.00 direct

SHANNON TIMOTHY M - Director

2020-05-26 M 12,923 $22.06 a 74,546 4,564,100.00 direct

RATCLIFFE LIAM - Director

2020-05-26 M 6,500 $22.06 a 6,500 686,500.00 direct

SHANNON TIMOTHY M - Director

2020-05-26 M 12,923 d 0 4,564,100.00 direct

RATCLIFFE LIAM - Director

2020-05-26 M 6,500 d 6,423 686,500.00 direct
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments